Cybrexa Therapeutics
PrivateLast Round
Series B
Mar 10, 2021
Total Funding Raised
$46.7M
Company Overview
Cybrexa Therapeutics is a biotechnology company focused on developing innovative oncology therapeutics that facilitate antigen-independent intracellular drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cybrexa Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Cybrexa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 10, 2021 | ||||
| Grant | Jul 2, 2019 | ||||
| Series B Extension | Jun 20, 2019 | ||||
| Series B | Jun 30, 2017 |
Cybrexa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Capital | Series B |
| National Cancer Institute | Grant |
| Connecticut Innovations | Series B Extension, Series B |
| HighCape Capital | Series B, Series B Extension |
| NIH RADx | Grant |
| Elm Street Ventures | Series B |
| Cycle Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2025
Presented data at the ESMO 2025 conference.
- Mar 5, 2025
Promising preclinical data on Tumor-Selective PDCs presented at ESMO 2025.
Cybrexa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cybrexa Therapeutics's valuation, stock price, and market status.
